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Abstract
·Celiac disease is an autoimmune disorder that affects
the small intestine of genetically predisposed individuals.
Ophthalmic manifestations are within the extra-intestinal
manifestations, and can be divided into those of
autoimmune disorders or those due to absorptive
disabilities. This article reviewed the ophthalmologic
manifestation of celiac disease. Ophthalmic symptoms
are rare, but should be investigated in patients with
celiac disease and taken into consideration as the first
systemic manifestation.
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INTRODUCTION
C eliac disease is an autoimmune disease that affects thesmall intestine of genetically predisposed individuals.
This disease can be asymptomatic and can have
gastrointestinal or extra-intestinal symptoms. The classic
symptoms are part of a malabsorptive syndrome with
diarrhea and weight loss. Approximately 50% of the patients
present with atypical or extra-intestinal symptoms, such as
anemia, osteoporosis, neurological disorders and dermatitis
herpetiformis [1-3]. Symptoms vary according to the genetic
predisposition, immune status, gender and age at onset [4].
Diagnosis is made when there is the presence of the genetic
factor (HLA DQ2/8), with a positive biopsy and the presence
of antibody serology [5]. The typical form of the disease
presents with crypt hyperplasia and villous atrophy in a
malabsorptive syndrome. The atypical form of the disease is
characterized by a positive serology, small changes in the
mucosa of the small intestine, or no gastrointestinal
symptoms associated with extra-intestinal symptoms,
including osteoporosis, peripheral neuropathy, anemia and
infertility [6-7]. The ophthalmic manifestations are within the
extra-intestinal manifestations, and can be divided into
autoimmune disorders and absorptive disabilities. The
manifestations related to malnutrion are correlated to the low
levels of vitamin A, vitamin D and calcium. It could cause
retinopathy, cataract, dry eye and pseudotumor cerebri. The
manifestations related to autoimmune disorders are orbital
myositis, uveitis, thyroiditis associated with orbitopathy and
brain occipital calcification.
Ophthalmologic Manifestations Related to Malnutrition
Retinopathy Retinopathy is characterized by yellowish to
white punctate lesions in the peripheral retina.
Electroretinogram (ERG) changes can occur, and vitamin A
levels are usually reduced in these patients [8-9]. A normal
vitamin A metabolism is important for the function of the
cones. The vitamin A deficiency can lead to night blindness
(nyctalopia) associated with ERG changes. Nyctalopia is
usually the first symptom in patients with vitamin A
deficiency, which may precede the symptoms of dry eye by
several months. Typically, visual function improves after one
to four months of vitamin A reposition[10].
Cataract Cataracts associated with celiac disease have been
reported in the literature[11-12]. Malabsorption can be caused by
chronic diarrhea. A severe vitamin D deficiency due to the
malabsorptive syndrome interferes with the absorption of
calcium, and the resulting hypocalcemia contributes to the
development of cataracts. Chronic diarrhea can also lead to
dehydration, which would alter the osmotic flow between the
lens and the aqueous humor, with alkalosis and high levels of
urea and ammonia. The lens maintains a good level of hydration
in an environment with calcium between 10-12 mg/100 mL.
Low levels of calcium in the aqueous humor change the
permeability of the lens epithelium, causing an imbalance in
the osmotic equilibrium and leading to lens opacification.
Hypocalcemia lasting 10-12mo is sufficient to generate
cataracts[13].
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Pseudotumor cerebri Pseudotumor cerebri, also known as
idiopathic intracranial hypertension, may be associated with
vitamin A deficiency, and is characterized by increased
intracranial pressure of unknown cause[14-15]. It may be caused
by nutritional, metabolic, endocrinological or hematological
disorders [16-17]. The association between vitamin A and
pseudotumor cerebri is more commonly reported associated
with vitamin A poisoning [18]. High levels of vitamin A may
damage the granulation of the arachnoid, hindering the
absorption of cerebrospinal fluid [19]. However, a few case
reports have described the relation between pseudotumor
cerebri and low levels of vitamin A [20-22]. The clinical picture
is characterized by the presence of papilledema with normal
radiological images and no other cause of increased
intracranial pressure [22]. The mechanism by which vitamin A
deficiency results in increased intracranial pressure is still not
fully understood. It was demonstrated, in animal models, that
vitamin A deficiency can increase the rate of the absorption
of cerebrospinal fluid, causing increased intracranial
pressure [23]. Studies have confirmed this mechanism
demonstrating fibrosis and increased arachnoid granules in
animal vitamin A deficiency [23]. One study suggested a
different mechanism of increased intracranial pressure caused
by vitamin A deficiency [24]; they found a decrease in the
volume of the cranial cavity and brain compression by
excessive cranial bone growth in dogs with vitamin A
deficiency. This increase in bone growth was noted in the
bones of the posterior fossa, thus affecting the cerebellum,
the pons and the medulla oblongata. Similar bone deformities
were demonstrated by scientists, who found an increase in
osteoblast activity in the periosteum, which led to a bone
deposit in the skulls of birds with vitamin A deficiency [25].
Vitamin A deficiency can be treated with oral
supplementation or, in the case of poor lipid absorption, with
muscular injection. Additional doses of vitamin A may be
required in patients with protein deficiency.
Dry eye Vitamin A is necessary to maintain the proper
functioning of the ocular epithelium surface. In the
conjunctiva, the loss of goblet cells, and the metaplasia of the
squamous cells can lead to dry eye condition in patients with
vitamin A deficiency. Bitot spots due to keratinization of the
perilimbal conjunctiva may be seen. In more severe cases,
liquefactive necrosis of the cornea (keratomalacia) may
occur [26]. Topical retinoic acid 0.1% can promote anatomical
improvement of the conjunctiva and the cornea[27].
Ophthalmologic Manifestations Due to Dysimmunity
Orbital myositis An association has been reported between
celiac disease and inflammatory myopathies. High levels
of anti-gliadin antibodies were found in patients with
myositis [28]. Celiac disease has also been associated with
neutrophil myositis [29]. An association between celiac disease
and dermatomyositis has been reported in patients, and these
two conditions may have a common immunological basis [30].
The pathophysiology of this disease is not yet clear, but it is
usually related to eosinophil and granulomatous infiltration[31].
Patients with orbital myositis usually have diplopia, pain with
eye movements and exophthalmos. It is more common in
women and affects only one extra-ocular muscle [28]. This
condition is well treated with corticosteroids[32-33].
Uveitis A recent study showed an association between
idiopathic uveitis and patients with celiac disease [34]. Uveitis
is an inflammation of the uvea, which can lead to vision loss.
Early diagnosis and prompt treatment is important to preserve
vision.
Thyroiditis associated with orbitopathy The etiology of
Hashimoto's disease is unknown, but patients usually have a
genetic predisposition, with the presence of HLA-DR3/DR4
or HLA-DQ2/DQ8 [35-40]. The pathogenesis of Hashimoto's
thyroiditis is multifactorial [41]. Endogenous hormones and
external factors are suspected to trigger the manifestations of
the disease[42].
Gastrointestinal immune diseases, such as celiac disease, are
more prevalent in patients with Hashimoto's thyroiditis.
Patients with celiac disease have four times more risk to
develop Hashimoto's thyroiditis. The pathogenesis of the
coexisting Hashimoto's thyroiditis and other autoimmune
diseases, such as celiac disease, is still not complete
understand [43-44]. The association between the orbital
manifestation of the thyroiditis and celiac disease is due to a
possible lymphocytic infiltration leading to tissue remodeling
and fibrosis [45-46]. The local release of pro-inflammatory
cytokines, tumor necrosis factors and interleukin-6 are
present both in Hashimoto's thyroiditis and in celiac
disease [47-48]. The presence of histocompatibility complex class
II (MHC II) has been described in both thyroiditis and celiac
disease[49-50].
Brain occipital calcification The neuro-ophthalmologic
manifestations result in local inflammatory alterations and
vasculitis caused by immunological mechanisms. Low vision
is rare in celiac disease, but has been correlated with cases of
cortical calcification in the occipital region[51-52].
A study indicated that HLA, predisposing to celiac disease, is
the same gene that is associated with bilateral occipital
calcification [53]. The cerebral calcification may be associated
with a reduction in the concentration of folate in the central
nervous system, due to poor absorption of folate and
transportation difficulties through the blood-brain barrier [54-56].
However, the pathophysiology of this alteration has not yet
been definitely determined. Folic acid deficiency is not
present in all patients with celiac disease and cerebral
calcification [57]. Another hypothesis is that the brain
calcification is due to an immune complex associated with
endothelial inflammation [57-58]. Further studies are needed to
elucidate the pathophysiology of occipital calcification.
Ophthalmologic manifestations of celiac disease
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CONCLUSION
Celiac disease has intestinal and extra-intestinal
manifestations, caused by immune alterations or by nutrient
malabsorption. The ophthalmic symptoms are rare within the
extraintestinal manifestations, but should be investigated in
patients with celiac disease and taken into consideration as
the first systemic manifestations of the disease[59-60].
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